Physician profile
Bryce Yantis
NPI 1841709862
$10,067.46
in general payments reported to CMS, 2019-2025
16 companies · $5,324 in 2025
The $5,324 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $1,064 · 2023: $405 · 2024: $3,106 · 2025: $5,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,357 · Food and Beverage: $3,060 · Consulting Fee: $2,408 · Education: $9.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,356.70 |
| Food and Beverage | $3,060.45 |
| Consulting Fee | $2,408.00 |
| Education | $9.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,661.12 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Attain Command + Surevalve |
| Biosense Webster, INC. | $632.34 | 2022-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Merck Sharp & Dohme LLC | $138.72 | 2025 | Verquvo |
| Cardiva Medical, INC. | $119.91 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Boston Scientific Corporation | $99.47 | 2023-2025 | Watchman Access System, Watchman |
| Abbott Laboratories | $86.65 | 2025 | Cardiomems, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $71.43 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.22 | 2023-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.66 | 2025 | Jardiance |
| Heartflow, INC. | $27.87 | 2024 | |
| Stryker Corporation | $25.77 | 2025 | Lifepak 35 |
| Elutia, INC. | $22.80 | 2022 | |
| Novo Nordisk INC | $22.70 | 2025 | Wegovy |
| Angiodynamics, INC. | $21.65 | 2024 | Alphavac |
| Novartis Pharmaceuticals Corporation | $18.85 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $15.30 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Yantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.